Lysine Pyruvylation (Kpy): A Glycolysis-Driven Protein Modification Regulating Gene Transcription

Concept: From Lactate to Pyruvate in Metabolite-Driven PTM Research

Lysine pyruvylation is a novel protein post-translational modification first systematically identified and characterized by the team of Huang at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, in 2026. Post-translational modifications form the central mechanism linking cellular metabolic state to protein function. In 2019, the same research collaboration identified lysine lactylation, demonstrating for the first time that lactate, the end product of glycolysis, can act as a PTM precursor and directly regulate gene expression. That discovery redefined lactate, previously considered a metabolic waste product, as an epigenetic signaling molecule. A key question followed naturally from this work. Pyruvate occupies a central metabolic junction, shares structural similarity with lactate, and interconverts with it readily, so researchers asked whether pyruvate likewise possesses the capacity to mediate protein modification. The systematic characterization of lysine pyruvylation answered this question and extended metabolite-driven PTM research from lactate to its upstream metabolite.

Chemical Pathway and Evolutionary Conservation of Kpy

Integrating biochemical assays with high-resolution mass spectrometry, the research team captured Kpy signals on mammalian histones and mapped ten histone Kpy sites together with seventy-eight non-histone Kpy sites. Importantly, Kpy was detected in Escherichia coli, yeast, and mammalian cells, indicating that the modification is highly conserved across evolution and likely carries fundamental biological functions. At the chemical level, the team identified pyruvoyl-CoA as the key metabolic intermediate connecting free pyruvate to protein Kpy modification. This established a complete chemical route proceeding from metabolite through coenzyme intermediate to covalent protein modification. Metabolic perturbation experiments further confirmed that Kpy levels fluctuate dynamically with glycolytic flux and intracellular pyruvate concentration, verifying pyruvate as the metabolic precursor of the modification.

Writer and Eraser Enzymes Shaping the Kpy Regulatory Loop

Dynamic reversibility of Kpy is guaranteed by a dedicated enzymatic control system identified through systematic screening of candidate acyltransferases and deacylases. Histone acetyltransferase HAT1 and p300, also known as EP300, function as writers that catalyze formation of Kpy from pyruvoyl-CoA. Notably, p300 had previously been confirmed as a common catalytic enzyme for multiple acylation modifications, including acetylation, crotonylation, and beta-hydroxybutyrylation, suggesting that Kpy may share regulatory networks with other acyl modifications through competition and coordination. The NAD-dependent deacylase SIRT3 serves as the eraser that removes Kpy from modified proteins. Elucidation of this writer-eraser loop provides the enzymatic basis for understanding how Kpy responds to cellular energy state, reflected in the NAD-plus to NADH ratio, and precisely modulates protein function.

Transcriptional Regulation and Research Significance

To explore the functional meaning of Kpy, the team applied CUT&Tag technology to generate a genome-wide distribution map of the modification. Kpy was significantly enriched at gene promoter regions across the genome. Combined transcriptome analysis by RNA sequencing then demonstrated that Kpy can drive transcriptional activation of specific target genes, including FGFR4, LGALS8, and RSPH4A, establishing a direct evidence chain from metabolic modification to gene expression control. Given the central position of pyruvate in the Warburg effect, the team also made an initial observation in esophageal squamous cell carcinoma tissue specimens obtained for research purposes, where tumor tissues showed markedly higher Kpy levels than adjacent non-tumor tissues. This observation suggests a possible role for Kpy in tumor metabolic reprogramming and provides a direction for further exploration of the modification in metabolism-related disease mechanisms. Together, these findings build a direct molecular link between pyruvate metabolism and epigenetic regulation and expand the landscape of metabolite-driven post-translational modifications.

Open Questions and Research Frontiers for Kpy

Several directions now define the research frontier for this modification. Crosstalk represents the first question, because p300 catalyzes acetylation, crotonylation, and beta-hydroxybutyrylation on overlapping substrate pools, and competition among acyl marks may redistribute chromatin occupancy under metabolic stress. Mapping studies that profile multiple modifications in parallel will clarify whether Kpy acts cooperatively or antagonistically with neighboring marks. A second question concerns NAD dependence, since SIRT3-mediated erasure ties Kpy dynamics to mitochondrial redox state, creating a potential mechanism by which energy status is transmitted directly to chromatin. Method development forms a third frontier, because site-level quantification demands enrichment strategies and mass spectrometry workflows tuned to the chemical properties of the pyruvyl group. Evolutionary comparisons across bacteria, yeast, and mammalian systems may further reveal whether Kpy serves conserved enzymatic roles or acquired gene-regulatory functions during eukaryotic evolution.

Metabolic perturbation experiments anchor all of these designs. Glycolytic flux manipulation through glucose restriction, pyruvate supplementation, or lactate dehydrogenase modulation provides orthogonal evidence that observed Kpy changes track pyruvate availability rather than unrelated stress responses. Reporting modification levels together with metabolite measurements strengthens causal interpretation across studies.

Finally, comparing Kpy dynamics across developmental stages and nutritional states may reveal physiological contexts in which pyruvate signaling dominates over other acyl modifications, positioning the modification within the broader economy of cellular metabolism.

Research Methods and Antibody Applications for Kpy Studies

Investigating Kpy biology requires detection reagents with high specificity for the pyruvylated lysine residue. Typical research workflows include Western blot assessment of global Kpy levels under metabolic perturbation, dot blot screening of modified synthetic peptides, and mapping studies combining enrichment with mass spectrometry. Substrate identification experiments test candidate modified proteins against site-directed mutants, while functional studies correlate modification levels with transcriptional output using CUT&Tag or chromatin immunoprecipitation approaches. A validated pan-Kpy antibody underpins each of these designs, and reagent specificity should be confirmed against related acyl-lysine modifications before deployment.

Within this workflow, ANT BIO PTE. LTD. provides the S-RMabMix™ Pyruvyl Lysine Rabbit mAb (S0B60315). This recombinant rabbit monoclonal antibody is rigorously validated to specifically recognize pyruvylated lysine residues on proteins and is suitable for Western blot and dot blot applications. It effectively supports core research needs in Kpy modification level detection, substrate identification, and metabolic epigenetic regulatory mechanism studies, with all applications restricted to basic research.

Related Products

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.